Epothilones and related structures - A new class of microtubule inhibitors with potent in vivo antitumor activity

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1470, Issue 3, 2000, Pages

  Altmann, Karl Heinz ^a   Wartmann, Markus ^a   O'Reilly, Terence ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPOTHILONE A; EPOTHILONE B; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; CYTOTOXICITY; DRUG MECHANISM; HELA CELL; HUMAN; MICROTUBULE; MICROTUBULE ASSEMBLY; PRIORITY JOURNAL; REVIEW;

EID: 0034678986     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-419X(00)00009-3     Document Type: Article

References (56)

1. M.C. Lu, in: W.O. Foye (Ed.), Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC, 1995, pp. 345-368.
2. Rowinsky E.K. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med. 48:1997;353-374.
3. Schiff P.B., Horwitz S.B. Taxol stabilizes microtubules in mouse fibroblasts. Proc. Natl. Acad. Sci. USA. 77:1980;1561-1565.
4. G. Höfle, N. Bedorf, K. Gerth, H. Reichenbach, Epothilone, deren Herstellungsverfahren so wie sie enthaltende Mittel, German patent disclosure DE 4138042, May 5, 1993 (priority Nov. 19, 1991).
5. Gerth K., Bedorf N., Höfle G., Irschik H., Reichenbach H. Epothilons A and B - Antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria)-production, physico-chemical and biological properties. J. Antibiot. 49:1996;560-564.
6. Bollag D.M., McQueney P.A., Zhu J., Hensens O., Koupal L., Liesch J., Goetz M., Lazarides E., Woods C.A. Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action. Cancer Res. 55:1995;2325-2333.
7. ter Haar E., Kowalski R.J., Hamel E., Lin C.M., Longley R.E., Gunasekera S.P., Rosenkranz H.S., Day B.W. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry. 35:1996;243-250.
8. Long B.H., Carboni J.M., Wasserman A.J., Cornell L.A., Casazza A.M., Jensen P.R., Lindel T., Fenical W., Fairchild C.R. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). Cancer Res. 58:1998;1111-1115.
9. Hamel E., Sackett D.L., Vourloumis D., Nicolaou K.C. The coral-derived natural products eleutherobin and sarcodictyins A and B: Effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry. 38:1999;5490-5498.
10. Mooberry S.L., Tien G., Hernandez A.H., Plubrukarn A., Davidson B.S. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents. Cancer Res. 59:1999;653-660.
11. Höfle G., Bedorf N., Steinmetz H., Schomberg D., Gerth K., Reichenbach H. Epothilone A and B - novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure, and conformation in solution. Angew. Chem. Int. Ed. Engl. 35:1996;1567-1569.
12. Kalesse M., Quitschalle M., Eckhard C., Gerlach K., Pahl A., Meyer H.H. The formal total synthesis of epothilone A. Eur. J. Org. Chem. 11:1999;2817-2823.
13. Schinzer D., Bauer A., Böhm O.M., Limberg A., Cordes M. Total synthesis of (-)-epothilone A. Chem. Eur. J. 5:1999;2483-2491.
14. Nicolaou K.C., He Y., Vourloumis D., Vallberg H., Roschangar F., Sarabia F., Ninkovic S., Yang Z., Trujillo J.I. The olefin metathesis approach to epothilone A and its analogs. J. Am. Chem. Soc. 119:1997;7960-7973.
15. Harris C.R., Kuduk S.D., Balog A., Savin K., Glunz P., Danishefsky S.J. New chemical synthesis of the promising cancer chemotherapeutic agent 12,13-desoxyepothilone B: discovery of a surprising long-range effect on the diastereoselectivity of an aldol condensation. J. Am. Chem. Soc. 121:1999;7050-7062.
16. Schinzer D., Bauer A., Schieber J. Syntheses of (-)-epothilone B. Chem. Eur. J. 5:1999;2492-2500.
17. White J.D., Sundermann K.F., Carter R.G. Improved synthesis of epothilone B employing alkylation of an alkyne for assembly of subunits. Org. Lett. 1:1999;1431-1434.
18. Mulzer J., Mantoulidis A., Öhler E. Easy access to the epothilone family - synthesis of epothilone B. Tetrahedron Lett. 39:1998;8633-8636.
19. White J.D., Carter R.G., Sundermann K.F. A highly stereoselective synthesis of epothilone B. J. Org. Chem. 64:1999;684-785.
20. Meng D., Bertinato P., Balog A., Su D.-S., Kamenecka T., Sorensen E.J., Danishefsky S.J. Total syntheses of epothilones A and B. J. Am. Chem. Soc. 119:1997;10073-10092.
21. Nicolaou K.C., Ninkovic S., Sarabia F., Vourloumis D., He Y., Vallberg H., Finlay M.R.V., Yang Z. The total synthesis of epothilones A and B via a macrolactonization-based strategy. J. Am. Chem. Soc. 119:1997;7960-7973.
22. Kowalski R.J., Giannakakou P., Hamel E. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol). J. Biol. Chem. 272:1997;2534-2541.
23. Wilson S., Jordan M.A. Microtubule dynamics: taking aim at a moving target. Chem. Biol. 2:1995;569-573.
24. Chou T.-C., Zhang X.-G., Balog A., Su D.-S., Meng D., Savin K., Bertino J.R., Danishefsky S.J. Desoxyepothilone B: An efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B. Proc. Natl. Acad. Sci. USA. 95:1998;9642-9647.
25. Meyer T., Regenass U., Fabbro D., Alteri E., Rösel J., Müller M., Caravatti G., Matter A. A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo antitumor activity. Int. J. Cancer. 43:1989;851-856.
26. Sepp-Lorenzino L., Balog A., Su D.-S., Meng D., Timaul N., Scher H.I., Danishefsky S.J., Rosen N. The microtubule stabilizing agents epothilones A and B and their desoxy derivatives induce mitotic arrest and apoptosis in human prostate cancer cells. Prostate Cancer Prostatic Dis. 2:1999;41-52.
27. Moasser M.M., Sepp-Lorenzino L., Kohl N.E., Balog A., Su D.-S., Danishefsky S.J., Rosen N. Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones. Proc. Natl. Acad. Sci. USA. 95:1998;1369-1374.
28. Jordan M.A., Wendell K., Gardiner S., Derry W.B., Copp H., Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56:1996;816-825.
29. M. Wartmann, J. Köppler, M. Lartigot, D. Fabbro, K.-H. Altmann, R. Kawai, J. Kühnöl, P. Ramstein, R. Aichholz, W. Blum, Epothilones A and B accumulate several-hundred fold inside cells, Abstract submitted for the 100th AACR meeting, March 2000.
30. Giannakakou P., Sackett D.L., Kang Y.K., Zhan Z., Buters J.T.M., Fojo T., Poruchynsky S. Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization. J. Biol. Chem. 272:1997;17118-17125.
31. Giannakakou P., Sackett D.L., Nogales E., Downing K.H., Fojo T. A β-tubulin mutation confers epothilone resistance in human cancer cells. Proc. Am. Assoc. Cancer Res. 40:1999;284.
32. Blagosklonny M.V., Schulte T., Nguyen P., Trepel J., Neckers L.M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. 56:1996;1851-1854.
33. Blagosklonny M.V., Giannakakou P., El-Deiry W.S., Kingston D.G.I., Higgs P.I., Neckers L., Fojo T. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death. Cancer Res. 57:1997;130-135.
34. Su D.-S., Balog A., Meng D., Bertinato P., Danishefsky S.J., Zheng Y.-H., Chou T.-C., He L., Horwitz S.B. Structure-activity relationships of the epothilones and the first in vivo comparison with paclitaxel. Angew. Chem. Int. Ed. Engl. 36:1997;2093-2096.
35. ®-resistant colon and epidermoid tumors.
36. P. Lassota, J. Bontempo, K.-H. Altmann, M. Wartamnn, T. O'Reilly, In vivo activity profile of the microtubule-stabilizing agent epothilone B (EPO906), Abstract submitted for the 100th AACR meeting, March 2000.
37. Nicolaou K.C., Finlay M.R.V., Ninkovic S., King N.P., He Y., Li T., Sarabia F., Vourloumis D. Synthesis and biological properties of C12,13-cyclopropyl-epothilone A and related epothilones. Chem. Biol. 5:1998;365-372.
38. Nicolaou K.C., Finlay M.R.V., Ninkovic S., Sarabia F. Total synthesis of 26-hydroxy-epothilone B and related analogs via a macrolactonization based strategy. Tetrahedron. 54:1998;7127-7166.
39. K.C. Nicolaou, S. Ninkovic, M.R.V. Finlay, F. Sarabia, T. Li, Total synthesis of 26-hydroxyepothilone B and related analogs, JCS Chem. Commun. 1997, 2343-2344.
40. Nicolaou K.C., He Y., Roschangar F., King N.P., Vourloumis D., Li T. Total synthesis of epothilone E and analogs with modified side chains through the Stille coupling reaction. Angew. Chem. Int. Ed. 37:1998;84-87.
41. Nicolaou K.C., Sarabia F., Ninkovic S., Finlay M.R.V., Boddy C.N. Probing the ring size of epothilones: total synthesis of [14]-, [15]-, [17]-, and [18]Epothilones A. Angew. Chem. Int. Ed. 37:1998;81-84.
42. Nicolaou K.C., Vourloumis D., Li T., Pastor J., Winssinger N., He Y., Ninkovic S., Sarabia F., Vallberg H., Roschangar F., King N.P., Finlay M.R.V., Giannakakou P., Verdier-Pinard P., Hamel E. Designed epothilones: combinatorial synthesis, tubulin assembly properties, and cytotoxic action against taxol-resistant tumor cells. Angew. Chem. Int. Ed. 36:1997;2097-2103.
43. Glunz P.W., He L., Horwitz S.B., Chakravarty S., Ojima I., Chou T.-C., Danishefsky S.J. The synthesis and evaluation of 12,13-benzodesoxyepothilone B: a highly convergent route. Tetrahedron Lett. 40:1999;6895-6898.
44. Balog A., Bertinato P., Su D.-S., Meng D., Sorensen E., Danishefsky S.J., Zheng Y.-H., Chou T.-C., He L., Horwitz S.B. Stereoselective syntheses and evaluation of compounds in the 8-desmethylepothilone A series: some surprising observations regarding their chemical and biological properties. Tetrahedron Lett. 38:1997;4529-4532.
45. Su D.-S., Meng D., Bertinato P., Balog A., Sorensen E.J., Danishefsky S.J., Zheng Y.-H., Chou T.C., He L., Horwitz S.B. Total synthesis of (-)-epothilone B: an extension of the Suzuki coupling method and insights into structure-activity relationships of the epothilones. Angew. Chem. Int. Ed. Engl. 36:1997;757-759.
46. Höfle G., Glaser N., Kiffe M., Hecht H.-J., Sasse F., Reichenbach H. N-oxidation of epothilone A-C and O-acyl rearrangement to C-19- and C-21-substituted epothilones. Angew. Chem. Int. Ed. Engl. 38:1999;1971-1974.
47. Sefkow M., Höfle G. Substitutions at the thiazole moiety of epothilone. Heterocycles. 48:1998;2485-2488.
48. Sefkow M., Kiffe M., Höfle G. Derivatization of the C12-C13 functional groups of epothilones A, B and C. Bioorg. Med. Chem. Lett. 8:1998;3031-3036.
49. Sefkow M., Kiffe M., Schummer D., Höfle G. Oxidative and reductive transformations of epothilone A. Bioorg. Med. Chem. Lett. 8:1998;3025-3030.
50. Nicolaou K.C., Roschangar F., Vourloumis D. Chemical biology of epothilones. Angew. Chem. Int. Ed. Engl. 37:1998;2014-2045.
51. Harris C.R., Danishefsky S.J. Complex target-oriented synthesis in the drug discovery process: A case history in the dEpoB series. J. Org. Chem. 64:1999;8434-8456.
52. Chou T.-C., Zhang X.-G., Harris C.R., Kuduk S.D., Balog A., Savin K.A., Bertino J.R., Danishefsky S.J. Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel. Proc. Natl. Acad. Sci. USA. 95:1998;15798-15802.
53. Winkler J.D., Holland J.M., Kasparec J., Axelsen P.H. Design and synthesis of constrained epothilone analogs: the efficient synthesis of eleven-membered rings by olefin metathesis. Tetrahedron. 55:1999;8199-8214.
54. Nogales E., Wolf S.G., Downing K.H. Structure of the αβ tubulin dimer by electron crystallography. Nature. 391:1998;199-203.
55. Ojima I., Chakravarty S., Inoue T., Lin S., He L., Horwitz S.B., Kuduk S.D., Danishefsky S.J. A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc. Natl. Acad. Sci. USA. 96:1999;4256-4261.
56. Wang M., Xia X., Kim Y., Hwang D., Jansen J.M., Botta M., Liotta D.C., Snyder J.P. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone. Org. Lett. 1:1999;43-46.